217 related articles for article (PubMed ID: 18419542)
1. Complement-dependent synergistic bactericidal activity of antibodies against factor H-binding protein, a sparsely distributed meningococcal vaccine antigen.
Welsch JA; Ram S; Koeberling O; Granoff DM
J Infect Dis; 2008 Apr; 197(7):1053-61. PubMed ID: 18419542
[TBL] [Abstract][Full Text] [Related]
2. Complement-mediated bactericidal activity of anti-factor H binding protein monoclonal antibodies against the meningococcus relies upon blocking factor H binding.
Giuntini S; Reason DC; Granoff DM
Infect Immun; 2011 Sep; 79(9):3751-9. PubMed ID: 21708990
[TBL] [Abstract][Full Text] [Related]
3. Combined roles of human IgG subclass, alternative complement pathway activation, and epitope density in the bactericidal activity of antibodies to meningococcal factor h binding protein.
Giuntini S; Reason DC; Granoff DM
Infect Immun; 2012 Jan; 80(1):187-94. PubMed ID: 22064712
[TBL] [Abstract][Full Text] [Related]
4. Cooperative serum bactericidal activity between human antibodies to meningococcal factor H binding protein and neisserial heparin binding antigen.
Vu DM; Wong TT; Granoff DM
Vaccine; 2011 Feb; 29(10):1968-73. PubMed ID: 21241734
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies to meningococcal factor H binding protein with overlapping epitopes and discordant functional activity.
Giuntini S; Beernink PT; Reason DC; Granoff DM
PLoS One; 2012; 7(3):e34272. PubMed ID: 22461909
[TBL] [Abstract][Full Text] [Related]
6. A Meningococcal Outer Membrane Vesicle Vaccine with Overexpressed Mutant FHbp Elicits Higher Protective Antibody Responses in Infant Rhesus Macaques than a Licensed Serogroup B Vaccine.
Beernink PT; Vianzon V; Lewis LA; Moe GR; Granoff DM
mBio; 2019 Jun; 10(3):. PubMed ID: 31213564
[TBL] [Abstract][Full Text] [Related]
7. Fine antigenic specificity and cooperative bactericidal activity of monoclonal antibodies directed at the meningococcal vaccine candidate factor h-binding protein.
Beernink PT; Welsch JA; Bar-Lev M; Koeberling O; Comanducci M; Granoff DM
Infect Immun; 2008 Sep; 76(9):4232-40. PubMed ID: 18591239
[TBL] [Abstract][Full Text] [Related]
8. 4CMenB vaccine induces elite cross-protective human antibodies that compete with human factor H for binding to meningococcal fHbp.
Veggi D; Bianchi F; Santini L; Lo Surdo P; Chesterman CC; Pansegrau W; Bechi N; Huang Y; Masignani V; Pizza M; Rappuoli R; Bottomley MJ; Cozzi R; Maione D
PLoS Pathog; 2020 Oct; 16(10):e1008882. PubMed ID: 33007046
[TBL] [Abstract][Full Text] [Related]
9. A Meningococcal Native Outer Membrane Vesicle Vaccine With Attenuated Endotoxin and Overexpressed Factor H Binding Protein Elicits Gonococcal Bactericidal Antibodies.
Beernink PT; Ispasanie E; Lewis LA; Ram S; Moe GR; Granoff DM
J Infect Dis; 2019 Mar; 219(7):1130-1137. PubMed ID: 30346576
[TBL] [Abstract][Full Text] [Related]
10. Binding of complement factor H to PorB3 and NspA enhances resistance of Neisseria meningitidis to anti-factor H binding protein bactericidal activity.
Giuntini S; Pajon R; Ram S; Granoff DM
Infect Immun; 2015 Apr; 83(4):1536-45. PubMed ID: 25644002
[TBL] [Abstract][Full Text] [Related]
11. Human factor H (FH) impairs protective meningococcal anti-FHbp antibody responses and the antibodies enhance FH binding.
Costa I; Pajon R; Granoff DM
mBio; 2014 Aug; 5(5):e01625-14. PubMed ID: 25161192
[TBL] [Abstract][Full Text] [Related]
12. A region of the N-terminal domain of meningococcal factor H-binding protein that elicits bactericidal antibody across antigenic variant groups.
Beernink PT; LoPasso C; Angiolillo A; Felici F; Granoff D
Mol Immunol; 2009 May; 46(8-9):1647-53. PubMed ID: 19286260
[TBL] [Abstract][Full Text] [Related]
13. Does binding of complement factor H to the meningococcal vaccine antigen, factor H binding protein, decrease protective serum antibody responses?
Granoff DM; Ram S; Beernink PT
Clin Vaccine Immunol; 2013 Aug; 20(8):1099-107. PubMed ID: 23740919
[TBL] [Abstract][Full Text] [Related]
14. Bactericidal antibody responses induced by meningococcal recombinant chimeric factor H-binding protein vaccines.
Beernink PT; Granoff DM
Infect Immun; 2008 Jun; 76(6):2568-75. PubMed ID: 18362128
[TBL] [Abstract][Full Text] [Related]
15. Importance of inhibition of binding of complement factor H for serum bactericidal antibody responses to meningococcal factor H-binding protein vaccines.
Konar M; Granoff DM; Beernink PT
J Infect Dis; 2013 Aug; 208(4):627-36. PubMed ID: 23715659
[TBL] [Abstract][Full Text] [Related]
16. Meningococcal Factor H Binding Protein Vaccine Antigens with Increased Thermal Stability and Decreased Binding of Human Factor H.
Rossi R; Konar M; Beernink PT
Infect Immun; 2016 Jun; 84(6):1735-1742. PubMed ID: 27021245
[TBL] [Abstract][Full Text] [Related]
17. Effect of complement Factor H on anti-FHbp serum bactericidal antibody responses of infant rhesus macaques boosted with a licensed meningococcal serogroup B vaccine.
Giuntini S; Beernink PT; Granoff DM
Vaccine; 2015 Dec; 33(51):7168-7175. PubMed ID: 26562320
[TBL] [Abstract][Full Text] [Related]
18. The effect of human factor H on immunogenicity of meningococcal native outer membrane vesicle vaccines with over-expressed factor H binding protein.
Beernink PT; Shaughnessy J; Pajon R; Braga EM; Ram S; Granoff DM
PLoS Pathog; 2012; 8(5):e1002688. PubMed ID: 22589720
[TBL] [Abstract][Full Text] [Related]
19. Synergic complement-mediated bactericidal activity of monoclonal antibodies with distinct specificity.
Natali EN; Principato S; Ferlicca F; Bianchi F; Fontana LE; Faleri A; Pansegrau W; Surdo PL; Bartolini E; Santini L; Brunelli B; Giusti F; Veggi D; Ferlenghi I; Norais N; Scarselli M
FASEB J; 2020 Aug; 34(8):10329-10341. PubMed ID: 32725956
[TBL] [Abstract][Full Text] [Related]
20. A meningococcal factor H binding protein mutant that eliminates factor H binding enhances protective antibody responses to vaccination.
Beernink PT; Shaughnessy J; Braga EM; Liu Q; Rice PA; Ram S; Granoff DM
J Immunol; 2011 Mar; 186(6):3606-14. PubMed ID: 21325619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
